Custom antibody development

We offer world-leading antibody development platforms based on a proprietary RabMAb® rabbit monoclonal platform, a phase display platform (AxioMx), and a next-generation sequencing platform (NGS-RabMAb®)

Applications

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application

Abreviews

Notes

IHC-P

Use at an assay dependent concentration.

Agglutination

Use at an assay dependent dilution.

Target

Relevance

Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Thank you for your enquiry and your interest in our products.
We can offer testing discount for untested species/application and also for images for tested application. I can confirm that ab24222 has not been tested yet in IHC; whilst ab2521 an...

Thank you for your enquiry.
The format of ab2521 is condensed supernatant with 15 mM sodium azide. No more supplements or buffers are added or necessary. We do not store this antibody in 1/20 volume 1M tris buffer solution, pH 8.
I hope this info...